ALCHEMAB THERAPEUTICS
Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases. They are building their transformative engine to identify novel drug targets and develop a broad pipeline of novel antibody therapeutics for hard-to-treat cancers, neurodegenerative conditions, and infectious diseases.
ALCHEMAB THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2019-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.alchemab.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
82.93 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Actinium Pharmaceuticals
Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Biopesticide Ltd.
Biopeszticid is a Plant Protection Research and Trade organization that specializes in wholesale of chemical products.
BSIM Therapeutics
Small Molecule Therapeutics against Transthyretin-Mediated Amyloidoses
Calypso Biotech
Calypso Biotech's vision is to give new hope to patients suffering from severe gastro-intestinal diseases.
ChargePoint Technology
ChargePoint Technology offers split butterfly containment valves and docking systems for the pharmaceutical, food, and chemical industries.
Deja
Modern Rituals & Natural Products from the Ancient Science of Ayurveda
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Oblique Therapeutics
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
ScarTec Therapeutics
ScarTec Therapeutics develops novel peptide-based technology for scar-free healing.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Upacjenta
Upacjenta is to popularize preventive laboratory tests among Polish women and Poles.
Current Advisors List
Current Employees Featured
Founder
Investors List
RA Capital Management
RA Capital Management investment in Series A - Alchemab Therapeutics
Lightstone Ventures
Lightstone Ventures investment in Series A - Alchemab Therapeutics
DCVC
DCVC investment in Series A - Alchemab Therapeutics
Dementia Discovery Fund
Dementia Discovery Fund investment in Series A - Alchemab Therapeutics
SV Health Investors
SV Health Investors investment in Series A - Alchemab Therapeutics
DHVC
DHVC investment in Series A - Alchemab Therapeutics
DCVC Bio
DCVC Bio investment in Seed Round - Alchemab Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-26 | Alchemab Appoints Young T. Kwon as Chief Executive Officer |
| 2021-11-15 | Alchemab Therapeutics Appoints Young T. Kwon, PhD as Chief Financial and Operating Officer |
Official Site Inspections
http://www.alchemab.com Semrush global rank: 4.34 M Semrush visits lastest month: 2.62 K
- Host name: 139.254.197.35.bc.googleusercontent.com
- IP address: 35.197.254.139
- Location:
- Latitude: 47
- Longitude: 8
- Timezone: Europe/Vaduz
